Skip to main content
. 2014 Nov 12;36(3):1053–1064. doi: 10.1002/hbm.22685

Table 1.

Demographic and clinical characteristics of the sample

Control mTBI PTSD mTBI+PTSD Test Statistic (χ 2 or F) P
N 38 19 31 45
Current PTSD: N (%) 23 (74) 37 (82) 0.71 n.s.
Females: N (%) 6 (16) 1 (5) 2 (6) 0 (0)a 8.24 .04
Prior civilian mTBI: N (%) 19 (50) 11 (58) 19 (61) 23 (51) 1.17 n.s.
Age, years: Mean (SD) 33.9 (8.8) 36.6 (9.4) 33.3 (9.3) 30.2 (6.2)b 3.09 .03
Number of deployments: N (%) 6.89 n.s.
1 19 (50) 6 (32) 20 (65) 18 (40)
2 14 (37) 10 (53) 8 (26) 19 (42)
3+ 5 (13) 3 (16) 3 (10) 8 (18)
Total duration of deployments, months: Mean (SD)c 22.1 (7.8) 28.2 (18.3) 16.7 (5.7)b 19.8 (8.6)b 5.20 .002
Total current PCSd: Mean (SD) 1.8 (2.3) 3.8 (2.2)a 3.8 (2.0)a 5.1 (2.0)a 17.41 <.001
Lifetime alcohol dependence: N (%) 7 (18) 5 (26) 16 (52)a 30 (67)a, b 22.65 <.001
Lifetime MDD: N (%) 7 (18) 7 (37) 22 (71)a 31 (69)a 31.29 <.001
a

Different than controls.

b

Different than mTBI.

c

Total duration of deployments could not be determined for five Controls, 2 PTSD, 3 mTBI, and 1 mTBI+PTSD.

d

A total of eight postconcussive symptoms were assessed: memory problems, poor balance, irritability, tinnitus, sensitivity to light, sensitivity to noise, headaches, and insomnia.

MDD, major depressive disorder; mTBI, mild traumatic brain injury; PCS, postconcussive symptoms; PTSD, post‐traumatic stress disorder.